Contemporary Management of HIV: ART Management in Heavily Treatment–Experienced Patients

Download this expert-authored slideset to review guidelines and key data on assessing virologic failure, current management options for patients with multiclass drug resistance experiencing treatment failure, and considerations for switching ART in patients with underlying resistance.
Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Eric S. Daar, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 637 KB
Released: March 3, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
ViiV Healthcare

Related Content

Slides from CCO: Switching ART in HIV: 3-drug therapy, oral 2-drug options, long-acting injectable 2-drug regimens, single tablet regimens (STRs)

Daniel R. Kuritzkes, MD Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD Released: June 7, 2021

Slides from Daniel Kuritzkes and CCO. Switching to long-acting cabotegravir: ATLAS and FLAIR data, starting, dosing regimens, avoiding treatment failure

Daniel R. Kuritzkes, MD Released: June 4, 2021

Drs Roger Bedimo, Princy N. Kumar, and Brian Wood, answer commonly asked questions on managing heavily treatment-experienced patients with HIV

Roger Bedimo, MD, MS, FACP Princy N. Kumar, MD, FIDSA, MACP Brian Wood, MD Released: June 2, 2021

Download free CCO slides reviewing a patient case and key data and guidelines on weight gain in aging persons with HIV

Karine Lacombe, MD, PhD Released: May 27, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue